| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5831883 | International Immunopharmacology | 2016 | 4 Pages |
Abstract
Our results imply that IL-23 may potentially play a role in the pathogenesis of RA and may be a useful biomarker for the diagnosis of this disease. Targeting the IL-23 cytokine may provide a new therapeutic approach in the treatment of RA.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Doaa S.E. Zaky, Eslam M.A. El-Nahrery,